Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a phase 2b, randomized, double-blind, placebo-controlled, dose-ranging,14-day dosing, 2-period crossover study in participants with chronic obstructive pulmonary disease (COPD).
Epistemonikos ID: bff7b394a64679712a871d117a2d344d8442009c
First added on: Oct 27, 2026